Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Spyre Therapeutics Inc. (NASDAQ: SYRE) closed at $29.88 in the last session, down -0.96% from day before closing price of $30.17. In other words, the price has decreased by -$0.96 from its previous closing price. On the day, 0.68 million shares were traded. SYRE stock price reached its highest trading level at $30.39 during the session, while it also had its lowest trading level at $28.75.
Ratios:
We take a closer look at SYRE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 19.70 and its Current Ratio is at 19.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on September 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $45.
On May 02, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $50.Robert W. Baird initiated its Outperform rating on May 02, 2024, with a $50 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 03 ’24 when Burrows Scott L sold 18,531 shares for $28.17 per share. The transaction valued at 522,074 led to the insider holds 116,422 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SYRE now has a Market Capitalization of 1521480576 and an Enterprise Value of 1262465920.
Stock Price History:
Over the past 52 weeks, SYRE has reached a high of $47.97, while it has fallen to a 52-week low of $8.43. The 50-Day Moving Average of the stock is 6.68%, while the 200-Day Moving Average is calculated to be 2.53%.
Shares Statistics:
According to the various share statistics, SYRE traded on average about 623.61K shares per day over the past 3-months and 682510 shares per day over the past 10 days. A total of 50.92M shares are outstanding, with a floating share count of 45.37M. Insiders hold about 10.90% of the company’s shares, while institutions hold 92.39% stake in the company. Shares short for SYRE as of 1724976000 were 8462948 with a Short Ratio of 13.57, compared to 1722384000 on 7811572. Therefore, it implies a Short% of Shares Outstanding of 8462948 and a Short% of Float of 19.709998000000002.
